We are live on
!
Find out more
BCM
Boone Capital Management Portfolio holdings
AUM
$326M
1-Year Est. Return
86.31%
This Fund
S&P 500
This Quarter
Est. Return
+5.47%
1 Year Est. Return
+86.31%
3 Year Est. Return
+255.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$294M
AUM Growth
-$2.64M
(-0.89%)
Cap. Flow
-$9.44M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
92.53%
Holding
16
New
3
Increased
2
Reduced
7
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$35.2M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$22M |
| 3 |
Intuitive Surgical
ISRG
|
+$21.5M |
| 4 |
Pennant Group
PNTG
|
+$1.99M |
| 5 |
Mirum Pharmaceuticals
MIRM
|
+$1.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$17.2M |
| 2 |
IDEAYA Biosciences
IDYA
|
+$13.5M |
| 3 |
IQVIA
IQV
|
+$11.2M |
| 4 |
Genworth Financial
GNW
|
+$10.7M |
| 5 |
Viking Therapeutics
VKTX
|
+$8.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 80.58% |
| 2 | Financials | 19.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Unum
UNM
$13.7B
| $57.1M | 19.42% |
700,600
-103,265
| -13% | -$7.96M |
|
|
2
Medtronic
MDT
$108B
| $35.4M | 12.04% |
+393,737
| New | +$35.2M |
|
|
3
Mirum Pharmaceuticals
MIRM
$6.55B
| $27.2M | 9.25% |
603,318
+21,475
| +4% | +$1.01M |
|
|
4
Globus Medical
GMED
$10.7B
| $26.4M | 8.99% |
360,764
-207,701
| -37% | -$17.2M |
|
5
Cigna
CI
$75.1B
| $23.3M | 7.93% |
70,859
-15,002
| -17% | -$4.52M |
|
|
6
BioMarin Pharmaceuticals
BMRN
$11.5B
| $23.1M | 7.87% |
+327,279
| New | +$22M |
|
7
Molina Healthcare
MOH
$10.2B
| $22.3M | 7.57% |
67,555
-14,287
| -17% | -$4.32M |
|
8
Perrigo
PRGO
$1.41B
| $19.8M | 6.73% |
704,824
-317,545
| -31% | -$8.23M |
|
|
9
Intuitive Surgical
ISRG
$126B
| $19.3M | 6.56% |
+38,930
| New | +$21.5M |
|
|
10
Pennant Group
PNTG
$1.4B
| $18.1M | 6.16% |
719,137
+77,882
| +12% | +$1.99M |
|
11
Orthofix Medical
OFIX
$467M
| $15.5M | 5.26% |
948,202
-109,111
| -10% | -$1.92M |
|
12
Biohaven
BHVN
$2.03B
| $6.5M | 2.21% |
270,198
-91,222
| -25% | -$3.22M |
|
|
13
Genworth Financial
GNW
$3.78B
| – | – |
-1,536,612
| Closed | -$10.7M |
|
|
14
IDEAYA Biosciences
IDYA
$3.44B
| – | – |
-524,868
| Closed | -$13.5M |
|
|
15
IQVIA
IQV
$38.3B
| – | – |
-57,141
| Closed | -$11.2M |
|
|
16
Viking Therapeutics
VKTX
$3.72B
| – | – |
-209,853
| Closed | -$8.44M |
|
Similar funds
ISFAN
JHWEPV
AFA
ECH
DCM
MVM
CCG
TC
Boone Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Boone Capital Management held 16 positions worth $294M, down 0.89% from $296M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Boone Capital Management withdrew a net $9.44M in Q1 2025, closing 4 positions and reducing 7 holdings. Its most notable exit was IDEAYA Biosciences, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 77% a quarter earlier, followed by Financials.
Against the trend, Boone Capital Management opened a new position in Medtronic worth $35.4M.
- Boone Capital Management's largest Q1 2025 buy was Medtronic: 393,737 shares worth $35.4M.
- Boone Capital Management added most to Pennant Group in Q1 2025, an estimated $1.99M increase.
- Boone Capital Management's biggest Q1 2025 reduction was Globus Medical, cutting an estimated $17.2M.
- Boone Capital Management fully exited IDEAYA Biosciences in Q1 2025, selling an estimated $13.5M.
- Boone Capital Management's ten largest holdings make up 93% of its $294M portfolio in Q1 2025.
- Boone Capital Management opened 3 new positions and closed 4 in Q1 2025.
- Boone Capital Management's portfolio value fell 0.89% quarter-over-quarter to $294M.
Based on Boone Capital Management's 13F filing for Q1 2025, filed 15 May 2025.